Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,375 | -26,563 | -180,664 | -131,565 | -81,667 |
| Depreciation Amortization | 3,298 | 1,658 | 6,546 | 4,892 | 3,202 |
| Income taxes - deferred | -877 | -767 | 3,306 | 3,588 | -3,683 |
| Accounts receivable | -232 | N/A | 2,482 | 2,482 | 52,358 |
| Accounts payable and accrued liabilities | -6,354 | -5,923 | 8,002 | 3,835 | 21 |
| Other Working Capital | -72,486 | -55,668 | 72,477 | 81,675 | 50,346 |
| Other Operating Activity | 27,530 | 16,394 | 27,223 | 21,753 | -32,892 |
| Operating Cash Flow | $-115,496 | $-70,869 | $-60,628 | $-13,340 | $-12,315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -432 | -12 | -2,929 | -2,878 | -2,376 |
| Investing Cash Flow | $-432 | $-12 | $-2,929 | $-2,878 | $-2,376 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 551,477 | 1,871 | 250,027 | 249,641 | 15,010 |
| Financing Cash Flow | $551,477 | $1,871 | $250,027 | $249,641 | $15,010 |
| Exchange Rate Effect | -608 | -416 | 1,346 | 57 | 960 |
| Beginning Cash Position | 526,970 | 526,970 | 339,154 | 339,154 | 339,154 |
| End Cash Position | 961,911 | 457,544 | 526,970 | 572,634 | 340,433 |
| Net Cash Flow | $434,941 | $-69,426 | $187,816 | $233,480 | $1,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -115,496 | -70,869 | -60,628 | -13,340 | -12,315 |
| Capital Expenditure | -432 | -12 | -2,929 | -2,878 | -2,376 |
| Free Cash Flow | -115,928 | -70,881 | -63,557 | -16,218 | -14,691 |